Author: Taco Tuinstra

Keynote: Hiroya Kumamaru,

Hiroya Kumamaru, vice director at Japan’s AOI Universal Hospital, gave a 15-minute overview of the current status of harm reduction in Japan.
Quoting 2019 figures, Kumamaru said that, as in many other countries, smoking is the biggest cause of death in Japan, though high blood pressure is not far behind and is catching up, probably because of the aging of Japanese society.
On top of this, he put forward the economic argument for reducing smoking, which, he said, while having a positive annual impact on the economy of ¥2.8 trillion ($18.76 billion), mainly through taxation, had a negative impact of ¥4.3 trillion mainly due to loss of labor because of smoking-related diseases, the medical costs associated with smokers and passive smokers, cleanups and fire-related expenses.
Kumamaru told how, about 15 years ago, he had started working in a small clinic in the center of Tokyo, where he became involved in a national smoking cessation program that was based on a three-month-long series of five visits by smokers to doctors. Although a lot of effort was put into the program, and nearly 60 percent of the participants at his clinic went on to complete the five outpatient visits, nine months after the end of the program, nearly half of those who had appeared to have quit started smoking again, a result he described as “disappointing.”
He then compared this with what had happened after the start of sales of heated-tobacco products (HTPs) from 2016. By 2019, almost one-third of male and one quarter of female tobacco consumers were using HTPs, a result that he described as “amazing.” As a result, total cigarette and HTP consumption was heading down while HTP consumption was increasing.
In part, his amazement sprang from the fact that while this was happening in Japan, it appeared not to be happening at the same level elsewhere, and he didn’t know why this was the case. For example, Japan’s smoking rate was decreasing at a faster rate than that of Australia, which had introduced very strict smoking restrictions but banned the sales of HTPs.
Notwithstanding Japan’s success with lowering smoking rates, many people in Japan remained skeptical about HTPs and raised issues about the unintended use of these products: dual usage, initiation, relapse and what is called in Japan the gateway effect of youth initiation. But these turned out not to be significant issues. Kumamaru said about 20 percent of smokers use HTPs and cigarettes, which is not that many. And initiation or re-initiation has been at a very low level, with two years of surveys recording a 2 percent factor in the first year and 1.3 percent in the second. In particular, youth initiation is low, and there has been no increase in initiation among younger people due to the launch of HTPs.
Kumamaru said that interesting data from Italy, Korea and Japan pointed to the fact that consumers of HTPs have better outcomes than smokers in respect of chronic obstructive pulmonary disease and cardiovascular disease while the exposure to carcinogens associated with HTP use is just 3 percent of that of smoking.
He ended his presentation by saying that Japan could look forward to a better future because of HTPs, though it is necessary to keep carrying out surveys and probably starting a long-term clinical study.
October 11, 2023
Fireside Chat: Robert Pye, Luis Sanches and Chris Greer

The Fireside Chat with Robert Pye, CEO of Filtrona, Luis Sanches, chief strategy officer at Greenbutts, and Chris Greer, president and CEO of TMA, offered insights into the environmental, social and governance (ESG) framework.
The chat started with a discussion of each company and what it does within the larger industry—Filtrona and Greenbutts are both in the filters aspect of the industry in different manners. Filtrona is a traditional and specialty filter supplier while Greenbutts is a material science company that has been working to introduce a more sustainable alternative to traditional cellulose acetate filters. While Filtrona has been in the industry for 80 years, Greenbutts is relatively new at 13—“a startup of sorts,” in the words of Greer.
Greer noted that Filtrona has many locations in Asia, with the headquarters being in Singapore, and brought up the idea of the 21st century being “the Asian century.”
“What attracted you to Singapore, first, and for your part of the industry, what are some key takeaways that you can give us about Asia and the marketplace and where that fits in, in the change and transformation part of things?” Greer asked Pye.
“I think Asia is, as you mentioned, a very dynamic place,” Pye said. “Our global head office is based in Singapore. We’re happily ensconced there because, I think if you think about our 2,000 employees, probably in Asia, we have maybe 1,500 of those 2,000 employees based in Asia. So it just makes sense to be in Singapore. And also our largest part of revenue and profits are based in Asia as well.
“So it just made sense for us to really base ourselves in Asia and really base our footprint around Asia. And the reason for being based around Asia is really that we see this being the most dynamic part of the industry for our industry as well. We see a lot of companies coming to Asia. Indonesia has had probably a lot of expansion over the last few years. That market’s still very interesting. Of course, I mentioned the China market, but India’s still interesting. And then you’ve got all the Southeast Asian countries, and they’re all very different, right? Whether they’re regulations or whether they’re cultural aspects or even tobacco-related industries within that country.”
Pye also expressed that Asia is willing to advance “whether it’s technology or whether it’s a market or whether it’s embracing something new.” He said countries “probably less developed than some other Western countries usually tend to leapfrog in a lot of areas of technology.”
Turning to Sanches, Greer said, “You’re in material science, you’re blazing your trail. What’s the biggest change that you’ve had to make in your thinking?” Sanches joined Greenbutts from BAT, a large company with lots of resources.
“It’s an interesting consideration,” Sanches said. “Because I think for a gearbox perspective, every company, regardless of its size, it needs the core to be properly functioned. For instance, you need to define your goals. … And regardless if you’re in startup, the organization needs to have this very well defined. Then you set up a strategy, and the strategy has to be the way you want to deliver those goals. And then you move to metrics, and then you move to engagement, primarily to whom you need to partner with and which organizations you need to be very close [with], the shareholders you need to bring to your organization, the stakeholders that get affected or being affected by you.
“So I think, in a sense, we share the same values. I think we share the same structure. … I think the biggest differences will be the size of the pocket for sure. Being part of a startup, funds and resources are not always there. So it’s more limited in terms of resources and talent footprint that Robert just mentioned. I think the other aspect is big organizations; they have very good governances. They sometimes, and most of them, they’re very bureaucratic. And the politics inside organizations drive you crazy and slow you down in every decision you need to make,” Sanches said. He noted that a big advantage to being a startup is flexibility.
Greer noted that ESG sometimes gets a “bad rap” as a buzzword and, in the spirit of changing the conversation, asked Pye and Sanches to talk about the real work behind ESG. “We see it in our business as being very important,” said Pye. “We want to be part of the solution. We see it makes great business sense, and we also see it makes great moral sense. You have a morality to it that you can flag and engage with your employees and your customers.”
“We are the largest producer of sustainable filters globally,” Pye continued. “I can sit on the stage and say that quite confidently. We work with all of the major suppliers in that area. We work with all the latest think tanks in that area, such as Greenbutts. But we also work with all the large customers and some small customers as well.
“We are a zero waste to landfill business. Any waste we generate, we use it to generate steam for our products.” Pye also noted that one of Filtrona’s sites has zero emissions and that the company uses solar panels on many of its sites as well.
Sanches added to that, noting that he made it clear in his early days with Greenbutts that the company could not “be seen as disruptors because disruption implies chaos” and the tobacco industry is a very efficient machine, so the company should focus on helping the industry transform itself without disrupting it.
“When we establish this as a premise in our ways of working, we say we need to ensure that the entire value chain is covered. We’re going to do the pre-work, ensure that we have all the sources of the material that you utilize well set up in a proper geography. The converters which convert fibers into substrate are well set up as well in a global scale. … Therefore, when the tobacco industry decides to adopt this or the biodegradable filters as their future solution today, we are all set up. So, not chaotic, not disruptive, but in a very gentle and very smooth way that we can introduce this.”
According to Sanches, Greenbutts aims to have the value chain covered so that companies can focus on other aspects. “We can help them in delivering their ESG targets,” he said.
The fireside chat highlighted what ESG looks like with tangible products and outcomes and pivoted the conversation away from targets toward real results.

October 11, 2023
Panel: Putting Consumers First

Toward the end of the Putting Consumers First panel held during September’s Global Tobacco and Nicotine Forum in Seoul, South Korea, Matt Drodge, research director at Walnut Unlimited, made the point that while nicotine consumers were all different, they all wanted to be able to make informed decisions about whether to continue smoking combustible cigarettes or when and how to make the transition to new nicotine products.
Of course, nicotine users can make such transitions only in countries where regulations allow them to do so, and the moderator of the panel, Nancy Loucas, public health policy expert and executive coordinator of the Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA), made the point that the panelists represented countries forming a continuum of nicotine regulation.
Panelist Samrat Chowdhery, former president of the International Network of Nicotine Consumer Organisations, told participants that he felt unhappy about representing India, a country that had put consumers last by effectively banning vapes. Chowdhery said this is a pity because India does not have a strong or widely used public health network, so prevention, including through the use of safer alternatives, is vital, as it is in other parts of the developing world where 80 percent of tobacco users live.
Fiona Patten, leader of the Reason Party and former member of the Legislative Council of Victoria, who was unable to attend the GTNF in person and instead recorded a video message, apologized for representing Australia, a country that she said is leading the way on what not to do around tobacco harm reduction. Patten said that Australia’s “so-called medical model” of regulation is so onerous that 99 percent of Australians who are looking for a safer way to consume nicotine are being forced onto the black market.
Alex Clark, CEO of the Consumer Advocates for Smoke-Free Alternatives Association, who also did not attend the event, but appeared via a live link, said the premarket tobacco product application (PMTA) system in the U.S. appears to consumers to be acting as a very tight bottleneck on the products they have access to; no flavored products have been authorized through the system, only variations of tobacco. Beyond the PMTA system, there was also concern that a methodical state-by-state, municipality-by-municipality effort to severely restrict the availability of lower risk products would continue. Clark said that while he hopes that in the future people will be able to find products they can trust, he questioned why there has to be a delay. What is needed now is to disseminate the idea that nicotine users are not just data on a spreadsheet and to get that message out, elevating it up the chain to the regulator.
Clarisse Yvette Virgino, a Philippines-based member of the CAPHRA, had a more positive tale to tell because a “wild journey” that had seemingly been headed toward prohibition had ended with regulation. The regulations were somewhat burdensome, however. Retailers had a lot of rules to comply with, and there was a problem when it came to consumer choice because manufacturers had withdrawn certain products, such as juices, rather than go through the process of complying with what were stringent requirements.
October 11, 2023
Cigarette Makers Turn to Menthol Substitutes

Image: Marisela
Cigarette manufacturers are deploying synthetic chemicals that mimic menthol’s cooling sensations in U.S. states that have banned the additive, according to a new study from Duke Health.
Menthol cigarettes are banned in California and Massachusetts and tobacco companies are bracing for a federal ban on the substance later this year.
In a Research Letter appearing online Oct. 9 in JAMA, researchers from Duke Health and Yale University identified new compounds that achieve similar cooling sensations to menthol, which has long been added to tobacco to reduce harshness.
“We found that tobacco companies are adding a synthetic cooling agent called WS-3 to these new “non-menthol” cigarettes,” said Sven-Eric Jordt, associate professor in the department of anesthesiology at Duke University School of Medicine and senior author of the study, in a statement. “The added amounts are sufficient to produce robust cooling sensations, with some brands having more cooling activity than their menthol equivalent cigarettes.”
When California’s menthol ban was enacted in December 2022, R.J. Reynolds Tobacco Co. and ITG Brands introduced non-menthol cigarette brands as menthol substitutes, with similar packaging and marketing strategies as their menthol cigarette brands.
Sairam V. Jabba, a senior research scientist at Duke and lead author of the study, measured whether cigarettes purchased in the two states with bans contain chemicals that activate the cold/menthol receptor, which senses environmental cold temperature and is activated by menthol.
“We found that four of the non-menthol cigarette products, all manufactured by R.J. Reynolds, robustly activated the cold/menthol receptor, and this cooling activity was stronger than of their menthol counterparts,” Jabba said.
“These results signify that these new ‘non-menthol’ cigarettes can produce the same cooling sensations as menthol cigarettes and thereby facilitate smoking initiation,” he said. “Allowing these cigarettes to be marketed would nullify several of the expected public health benefits from state and federal bans of menthol cigarettes.”
A chemical analysis of the “non-menthol” cigarettes detected a synthetic cooling agent, named WS-3, in four of the nine currently marketed products. WS-3 produces a cooling effect, but lacks the minty smell of menthol, allowing these products to bypass regulations. The researchers also detected vanilla and tropical flavor chemicals in “non-menthol” cigarettes, contained in flavor capsules in the filters.
“Our discovery of restricted flavors such as vanilla, which have characteristic odor and taste, demonstrates that Big Tobacco is ignoring current federal regulations banning the addition of characteristic flavors to cigarettes. More importantly, vanilla flavor is a very popular among children and youth, making it easy for them to initiate on these cigarettes,” Jordt said.
October 11, 2023
Zimbabwe Shifts Focus to Value Addition

Photo: Screaghin
Having nearly achieved its targeted leaf volumes, Zimbabwe is shifting its emphasis to promoting exports of value added tobacco products, reports The Herald.
The Tobacco Value Chain Transformation Plan (TVCTP) aims to capture more value from the tobacco industry by producing larger crops and moving beyond leaf cultivation. Among other things, it calls on farmers to produce a tobacco crop of 300 million kg by 2025.
In the most recent market season, Zimbabwe sold more than 290 million kg of tobacco. The seedbed for the country’s 2023-2024 is 15.5 percent larger than in the previous season, making it likely that Zimbabwe will achieve its target volume ahead of schedule.
“There has been an increase in volume as a result of post-harvest loss reduction and yield increase,” said Information, Publicity and Broadcasting Services Minister Jenfan Muswere following an Oct. 10 cabinet meeting. “During the 2022-2023 season a record 296.1 million kilograms of tobacco, worth $896 million was produced.
Satisfied with the progress made in increasing volumes, the sector is now turning its attention to value addition.
“There are opportunities to increase the level of value addition and beneficiation of tobacco into cut rag and cigarette production from 2 percent of tobacco produced to 30 percent,” said Muswere. “The construction of a new cigarette manufacturing plant and cut rag processing factories is underway and this will result in an increase in processing capacity by 50 percent in the first half of 2024.”
October 11, 2023
COP10 to Reject Harm Reduction: Briefing

Photo: Alesmunt
Tobacco harm reduction will be absent at the 10^th Conference of the Parties (COP10) to the Framework Convention on Tobacco Control (FCTC), according to new briefing paper published by the Global State of Tobacco Harm Reduction (GSTHR).
Scheduled for Nov. 20-23 in Panama City, COP10 will have a significant influence how tobacco policies are implemented at a national level, which in turn will determine the future of safer nicotine products such as e-cigarettes, heat-not-burn products and nicotine pouches.
To determine the potential impact of the conference on tobacco harm reduction, the GSTHR analyzed the COP10 agenda and supporting documents.
The GSTHR’s analysis indicates that at present, tobacco harm reduction and its potential to reduce smoking-related death and disease are entirely missing from the proceedings. The publicly available documentation ahead of the FCTC COP10 presents safer nicotine products as a threat to tobacco control rather than as potential tools to support a switch from smoking and reduce high-risk tobacco use.
Parties to the FCTC are expected to be encouraged to classify and regulate nicotine vapes, snus, nicotine pouches and heated tobacco products in the same way as tobacco and combustible tobacco. This risks removing or reducing access to safer options from people who already use them and may return to smoking—and from people who smoke and have the potential to switch and improve their health, according to the GSTHR, which is a project of Knowledge Action Change (KAC).

The WHO and FCTC Secretariat’s refusal to engage with evidence from multiple countries that have witnessed accelerated declines in smoking rates is unscientific and unjustifiable.
Gerry Stimson, director, KAC
“Having observed the WHO’s activities on this issue for some time, many are unsurprised that the FCTC COP10 meeting papers reveal a concerning direction of travel,” said KAC Director Gerry Stimson in a statement.
“The WHO and FCTC Secretariat’s refusal to engage with evidence from multiple countries that have witnessed accelerated declines in smoking rates is unscientific and unjustifiable. Their repeated characterization of safer nicotine products as a threat to tobacco control runs directly counter to what should be the overarching goals of the Convention–to reduce smoking-related deaths and disease as rapidly and effectively as possible.
“People who use safer nicotine products are barred and have no voice at the FCTC COP10. Those Parties who have successfully adopted and supported access to these products as effective tools for smoking cessation must ensure that their own progress is not hindered by COP decisions—and that the potential for tobacco harm reduction is given due consideration by all Parties present in Panama next month.”
October 10, 2023
Panel: Reinforcing Scientific Research

During the Reinforcing Scientific Research panel held as part of September’s Global Tobacco and Nicotine Forum in Seoul, South Korea, New Zealand-based Marewa Glover, director of the Center of Research Excellence on Indigenous Sovereignty and Smoking, made the point that the forum had heard many times how there is a need for tobacco and nicotine policies to be grounded in science and, therefore, evidence-based. There is, in fact, no disagreement on this point between tobacco control officials and tobacco harm reduction (THR) advocates, she said. However, care needs to be exercised because a form of evidence has been appropriated by some opposed to THR, and they are driving a broad social change agenda aimed at instituting a utopia where, for instance, no one would ever use drugs. They used scientific platforms loaded with people who shared their views to spread their ideology. They redefined the meanings of words so that unproven assertions became facts and facts became lies. To combat such views, she added, it is necessary for THR advocates to produce demonstrably robust research as part of a project that includes a communication strategy identifying stakeholders and how the information is to be gotten to them.
Glover had been asked three questions by moderator, Mark Littlewood, director general of the Institute of Economic Affairs: What needed to be done to reinforce scientific research into tobacco and nicotine?; who should form the audience for the research findings?; and how should the findings of junk science be challenged?—questions he also posed to the rest of the panel.
Kai-Jen Chuang, professor in the Department of Public Health at Taipei Medical University, explained that THR is not taught as part of medical degrees in Taiwan and therefore is not a well-recognized term, even though harm reduction principles are engaged in other areas. In fact, vapes were banned in Taiwan on March 22 this year. What is taught is health promotion and, more latterly as part of social-work courses, disaster reduction. He pointed out, nevertheless, that health promotion, disaster reduction and THR have similar goals, so those from outside Taiwan wishing to engage at conferences with public health officials over THR principles should present their papers, translated into Chinese, as health promotion studies. Nevertheless, he warned that it would be difficult, because of their training, to convince public health people of all stripes of the efficacy of using new technology to reduce the harm caused by smoking. The starting point for getting across messages about THR, he added, should be scholars with open minds, and from there, the focus could move to journalists and politicians.
Riccardo Polosa, professor of internal medicine at the University of Catania and founder of the Center of Excellence for the Acceleration of Harm Reduction (CoEHAR), said there is a need to reinforce quality science that has good repeatability. Repeatability, he added, is currently in crisis and not just in respect of tobacco control science, so the CoEHAR has established a comprehensive repeatability program pertaining to research into toxicity and biology in respect of combustion-free, nicotine-containing products. The program involves setting up and researching in seven laboratories with the same equipment and the same procedures to come up with super strong findings. Another thing that is needed, Polosa said, is to shift the focus from risk to harm. Relative risk has been studied for a decade now, and it is an easy win if combustible products are compared with combustible-free products. So now is the time to look at the absolute risk and show that it is low and that the level of harm is super low. This would provide a better position from which to convince governments, regulators and the public. Polosa had some good news on junk science, which he said is easy to debunk because it is junk, though this takes energy and time and requires a willingness to do it. A global network of scientists is actively rebutting junk science articles, though the challenge now is to speed up this process of rebuttal.
Picking up on an earlier comment about uncertainty, Konstantinos Farsalinos, research fellow at the Onassis Cardiac Surgery Center, made the point that uncertainty is inherent in science and essential to human progress. There is nothing wrong with uncertainty provided that it is not used to maintain the status quo, especially where the status quo has failed miserably. It is important, also, that uncertainties are not used as the basis for decision-making, which needs to be based on current knowledge. But one problem being faced today is that current knowledge is not being used to make decisions [about THR]; rather, decisions are being made on the back of the abuse of uncertainties [that the long-term use of THR strategies are unknowable at this stage]. Revisiting the 1986 Ottawa Charter for Health Promotion by the World Health Organization, Farsalinos said, it is obvious that it was basically talking about harm reduction in our everyday lives. Everything, even medicine itself, was a harm reduction science because it was not possible, probably, to cure any disease besides certain infections. We were treating diseases and reducing the adverse effects and consequences of diseases. This was all known. What is needed now is the reinforcement of the applicability of scientific data, of which there is a lot, on decision-making, something that has not happened in many parts of the world. Finally, Farsalinos said that he has had bad experiences in rebutting junk science even though he has been successful. Basically, he had run into a wall behind which people had decided what they believed and were casting around for the data to support their predetermined views. With science, you have to do the opposite of that, he said.
October 10, 2023
Keynote: Julian Cheung

The 2023 GTNF conference theme of “Change the Conversation. Change the Outcome.” was reiterated by keynote speaker Julian Cheung, anti-illicit trade operations director for Japan Tobacco International’s Asia-Pacific region. Cheung spoke on changing the conversations about illegal trade.
Before working with JTI, Cheung worked for the Independent Commission Against Corruption in Hong Kong, bringing much experience to the subject of anti-illicit trade.
She noted that there are many aspects to anti-illicit trade operations, including investigations, collecting evidence and looking at the forensics of samples. JTI works closely with law enforcement agencies to stop illicit trade, according to Cheung.
Behind the contraband, Cheung said, is often organized crime, which takes advantage of shifts in supply and demand and sees tobacco as a “high-profit, low-risk” market.
The illicit tobacco trade “impacts us all,” she said. Many jurisdictions have attempted to limit tobacco product usage and illicit trade through increased excise taxes, which has only led to more illicit trade—back to supply and demand; the demand is high, and if organized crime can offer supply at lower prices, they will profit rather than the licit industry. Online commerce, too, has made it easier for illicit products to flood the market. Consumers do not have an easy way to determine whether the products they order online are illicit or legal, regulated products. Online sales increased during the Covid-19 pandemic as many “nonessential” businesses closed either temporarily or permanently.
Cheung expressed a need for greater cooperation between governments, industry and law enforcement agencies at national and international levels to help combat illicit trade. The tobacco industry has a role to play, she said. Policies should be better balanced with deterrents that disrupt the financial gain of criminal networks.
“Let’s switch the narrative on illegal trade and act together,” Cheung said. “Through innovative strategies, cooperations and a focus on disrupting the financial foundation of these criminal networks, we can curtail the illegal trade and safeguard our communities and economies.”
October 10, 2023
Keynote: Brian King

When Brian King speaks, people come to listen. The U.S. Food and Drug Administration’s Center for Tobacco Products (CTP) director’s keynote address was easily the best attended session of GTNF 2023. King’s speech served as an overview of the current state of the CTP and an outline of the center’s main priorities over the next few years.
King said that the CTP has made considerable progress in reducing combustible cigarette smoking in the United States, which he contends as one of the most remarkable public health achievements of the past century. He hopes that those declines continue, given that “we do know” that combustible smoking is responsible for the overwhelming burden of death from using combustible tobacco.
Tobacco use continues to cost the U.S. government a considerable amount of money—to the tune of $600 billion per year from both direct healthcare costs and lost productivity, according to King. He said there are important human health benefits as well as financial benefits for regulators to continue to focus on reducing combustible use in the United States. As a part of this focus, he said, the CTP is continuing to make inroads when it comes to premarket tobacco production application review.
“We have a new director of our Office of Science who has jumped in headfirst to continue to fiercely lead our 550-plus scientists on application review …. We have processed 99 percent of those and continue to finalize the remaining 1 percent. I’m hopeful that in the coming months and years, we will get back to what was intended to be a premarket approval process,” said King. “In the meantime, we have authorized 23 e-cigarettes, all tobacco flavored. So, it is possible. We have had successful authorizations. But again, I can’t reinforce enough the importance of providing that sound and robust science to inform on potential authorization.
“And it is possible, as you can see. There will be more authorizations in the future, but it’s important that we have that science to support those decisions. As I noted earlier, we also continue to fold in the nontobacco nicotine work into our broader portfolio around regulation. We did receive a million applications, which I don’t think anyone anticipated. I will say that we are making great numbers. We are 99.9 percent through with the review of those. I will say that 100 percent is very imminent.”
King said that when it comes to products that are illegally on the market (having received a marketing authorization and are not currently under review by the CTP), the CTP is mindful of the importance in exercising all authorities that it has to ensure that people are complying with the law. He said that the FDA has given retailers the information they need to comply with the law through a list of authorized products (the 23 products that have been authorized for sale). The CTP also continues to ramp up efforts in terms of training, education and outreach across the supply chain, particularly to retailers.
“We also continue to do surveillance inspection investigations. This is something that occurs on a daily basis. We have arrangements with all 50 states and territories to continue to do investigations. We have issued many warning letters for flavored disposable e-cigarettes, which we know are particularly popular for youth,” said King. “There’s been a variety of blitzes that have occurred monthly throughout the summer. I will say there are more to come. We are going to continue to conduct those blitzes and making sure that we are routinely monitoring, particularly with a focus on those products that we know have high youth appeal.
“On balance, we are also continuing to do work around issuing import alerts. I was a little tickled by all the attention that the import alert on Elf Bar got. That’s nothing new, folks. We’ve been doing that for many years. It was suggested it was something seismographic, but we’ve been doing import alerts for quite some time. And we do use those as, again, another tool in our toolkit to make sure that we are addressing not only the products that are already in the country but preventing illegal products from entering the country.”
As of Sept. 31, the FDA has issued over 1,200 warning letters for online investigations. For manufacturers, the CTP has sent more than 800 warning letters, with more than 750 letters for e-cigarettes. Beginning earlier this year, the FDA also issued the first civil money penalties against manufacturers for violations for illegal e-cigarette sales. He said civil money penalties will remain a part of the CTP’s tools to combat illicit sales.
“We also issued the first six injunctions in coordination with the Department of Justice. I got a lot of flak for that as well about enlisting the Department of Justice. And I will remind folks that the FDA doesn’t have an independent litigation authority. If folks do not comply with the law, we will escalate further, as has been evidenced by these actions, which again are going to be part of our broader portfolio moving forward,” said King. “Everyone is going to be held accountable across the supply chain. We do want to make sure that we address the bad actors in a meaningful way. We also continue to pursue no tobacco sale orders among retailers as well. This has traditionally been issued for underage sales. But again, we’re committed to using the full scope of our authorities granted through Congress.”
King added that education is also a priority for the CTP. The center is ramping up efforts to address misinformation in the continuum of risk for nicotine products. He mentioned that he recently wrote a commentary where he highlighted the importance of opportunities and considerations for addressing misperceptions in nicotine. “There is science that exists in that there are misperceptions around the continuum of risk and also nicotine. And so, we do have opportunities that are present, but we have to follow the data-driven pandemic-based approach,” he explained. “That said, I’m putting my money where my mouth is …. We’re working with the National Institutes of Health for a funding opportunity to get more data on public health communication messaging about the continuum of risk.
“And as noted in that funding announcement, we’re looking for data both for the target population, which is called smokers, but also unintended populations, particularly youth. This is several million dollars on an annual basis, and we look forward to that kickstarting and getting data to inform our work.”
King said the CTP will also continue to gather input from the industry and the public. The CTP is creating a new office within the Office of the Center Director and is looking to hire a new director for Policy and Partnerships. “That posting is public,” he said. “And I’m looking forward to seeing those who have applied and getting someone in that seat to meaningfully oversee the product regulation portfolio across the center, particularly as we get that strategic plan in place.”
During the closing of his address, King said that he continues to be big on communication and stakeholder engagement. He expects to provide the industry with more opportunities for communication with the CTP. “I know that you’ll see in the future an evolution of our messaging. Both through our press releases, our social media and our [overall] messaging to make sure that we are clearer, simpler and more digestible,” he said. “I’ve been a bureaucrat for many years, but that doesn’t mean that I can’t communicate effectively with the general public. I think we can do better. I know we can do better.”
October 10, 2023
JTI Calls for Greater Cooperation Against Illicit Trade

JTI called for greater international cooperation between government agencies, industry and law enforcement in tackling the illicit trade in cigarettes.
Speaking at the Global Tobacco and Nicotine Forum (GTNF) in Seoul, Sept. 19-21, Julian Cheung, the anti-illicit trade operations director for JTI’s Asia-Pacific region, warned that criminal groups involved in the illegal tobacco trade, siphon much-needed tax revenue from state budgets. “They don’t comply with laws and regulations and, therefore, taxpayers, governments and legitimate businesses are all paying a hefty price,” she noted.
“Billions of dollars in revenue are lost to this criminal activity,” said Chueng. In 2019, the World Bank estimated the cost of the illicit tobacco trade to governments at between $40 billion and $50 billion annually.
“Let’s shift the narrative surrounding illegal trade and act together,” said Chueng in her presentation. “Through innovative strategies, cooperation and a focus on disrupting the financial foundations of these criminal networks, we can curtail the illegal tobacco trade, and safeguard our communities and economies.”
Chueng’s call for action fit well with the GTNF’s theme, “Change the Conversation. Change the Outcome.” The conference brought together hundreds of stakeholders from across the industry, including businesses, research consulting groups, scientists, public policy and regulatory experts and educators, to discuss industry trends and challenges and share best practice thinking.
September 24, 2023